INTERPACE BIOSCIENCES, INC. Business Acquisition, Pro Forma Net Income (Loss)
INTERPACE BIOSCIENCES, INC. (IDXGD) reported Business Acquisition, Pro Forma Net Income (Loss) of $24.30 million for the 12-month period ending 2014-12-31, per its 10-K filed 2016-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2016-03-30
- INTERPACE BIOSCIENCES, INC. business acquisition, pro forma net income (loss) for fiscal 2014 was $24.30M.
- INTERPACE BIOSCIENCES, INC. business acquisition, pro forma net income (loss) for fiscal 2013 was -$9.85M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 12 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month as first filed |
|---|---|---|
| 2014-12-31 | $24.30M 10-K · filed 2016-03-30 | -$24.30M 10-K · filed 2015-03-05 |
| 2013-12-31 | -$9.85M 10-K · filed 2015-03-05 |